Google has confirmed that some customers' information has been stolen in a recent breach of one of its databases.
Salesforce.com (CRM) concluded the recent trading session at $247.49, signifying a -1.91% move from its prior day's close.
I am upgrading Salesforce to a 'buy' with a $328 price target, seeing a 31% upside potential after a 30% multiple compression YTD, despite no change in earnings estimates. Agentforce's new consumption-based pricing and recent updates with Agentforce 3 could drive accelerated adoption and revenue growth, which the market is underestimating. The pending Informatica acquisition will strengthen Salesforce's data platform, creating a flywheel for Agentforce and AI-driven growth.
Salesforce still trades at a significant valuation discount over its long-term average. SaaS rivals like Palantir have spurred significant gains, while CRM struggles for traction. Management recognizes the urgency to embed Agentic AI and accelerate AI ARR growth, but execution remains the key to regaining investor confidence and valuation re-rating.
Salesforce continues to deliver strong results, highlighted by resilient revenue growth and a committed share repurchase program. The Informatica acquisition is attractively valued, contrasting with past expensive deals, and should create substantial shareholder value through cross-selling opportunities. Management remains committed to profitability and shareholder returns, with a strong balance sheet and hints of sustained growth.
ServiceNow NOW and Salesforce CRM are leading workflow automation platforms, helping enterprises streamline operations through cloud-based software and AI-powered tools. Platforms provided by these companies are widely used by large enterprises to drive efficiency and improve service delivery.
Salesforce.com (CRM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The latest trading day saw Salesforce.com (CRM) settling at $267.39, representing a -1.06% change from its previous close.
Shares of Salesforce Inc. ( NYSE: CRM ) lost 1.58% over the past month, dragging down the stock's year-to-date loss to 18.61%.
VEEV stock climbs 36% YTD as it accelerates its shift off Salesforce, betting on Vault to power future growth in life sciences.
In the most recent trading session, Salesforce.com (CRM) closed at $267.22, indicating a +1.38% shift from the previous trading day.
VEEV's split from Salesforce sets the stage for a high-stakes CRM showdown as both firms double down on life sciences innovation.